Armstrong Advisory Group
SLS icon

Armstrong Advisory Group’s SELLAS Life Sciences SLS Stock Holding History

Armstrong Advisory Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.68K Hold
380
– – ﹤0.01% 805
2026
Q2 		$5.61K Buy
+380
New +$2.62K ﹤0.01% 779

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Fulcrum Wealth Advisors
Fulcrum Wealth Advisors Bellevue, Washington $144M AUM 21.17% 1-Year Est. Return
Accurate Wealth Management
Accurate Wealth Management Wesley Chapel, Florida $1.16B AUM 24.67% 1-Year Est. Return
Instrumental Wealth
Instrumental Wealth Tampa, Florida $206M AUM 16.83% 1-Year Est. Return
Axxcess Wealth Management
Axxcess Wealth Management Carlsbad, California $2.44B AUM 16.42% 1-Year Est. Return
Genesee Capital Advisors
Genesee Capital Advisors Auburn, New York $318M AUM 26.07% 1-Year Est. Return
ELCO Management
ELCO Management New York $213M AUM 25.23% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return

Armstrong Advisory Group's SLS Position: Q3 2026 in Review

Armstrong Advisory Group held its SELLAS Life Sciences (SLS) position steady in Q3 2026 at 380 shares worth $4.68K. The position accounts for ﹤0.01% of the portfolio, ranked #805.

Armstrong Advisory Group first reported a position in SLS in Q2 2026 and has held it in 2 quarters since. The position peaked at $5.61K in Q2 2026. 26 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Armstrong Advisory Group held 380 shares of SELLAS Life Sciences worth $4.68K as of Q3 2026.
  • Armstrong Advisory Group left its SELLAS Life Sciences share count unchanged in Q3 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #805 holding.
  • Armstrong Advisory Group first reported a position in SELLAS Life Sciences in Q2 2026 and has held it in 2 quarters since.
  • Armstrong Advisory Group's SELLAS Life Sciences position peaked at $5.61K in Q2 2026.
  • 26 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.